Trail Ridge Investment Advisors, LLC Pfizer Inc Transaction History

Trail Ridge Investment Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $9,282 - $10,740	257 Added 4.71%	5,710 $209,000
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $69,877 - $90,970	-1,774 Reduced 24.55%	5,453 $222,000
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $43,420 - $56,680	1,040 Added 16.81%	7,227 $370,000
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $236,916 - $289,215	-5,414 Reduced 46.67%	6,187 $295,000
Q2 2022 Aug 02, 2022	BUY	$46.53 - $55.17 $17,262 - $20,468	371 Added 3.3%	11,601 $608,000
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $44,469 - $55,102	972 Added 9.48%	11,230 $581,000
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $423,860 - $628,302	10,258 New	10,258 $605,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Trail Ridge Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Trail Ridge Investment Advisors, LLC with notifications on news.